ERKNet

The European Rare Kidney Disease Reference Network

  

Journal Watch

Hereditary glomerulopathies

Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific Coq6 Knockout Mice.
Author(s): Widmeier E, Airik M, Hugo H, Schapiro D, Wedel J, Ghosh CC, Nakayama M, Schneider R, Awad AM, Nag A, Cho J, Schueler M, Clarke CF, Airik R, Hildebrandt F
Source: J Am Soc Nephrol 2019 Feb 8;
Publication date: 2019-02-8
C3 glomerulopathy - understanding a rare complement-driven renal disease.
Author(s): Smith RJH, Appel GB, Blom AM, Cook HT, D'Agati VD, Fakhouri F, Fremeaux-Bacchi V, Józsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Córdoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM
Source: Nat Rev Nephrol 2019 Jan 28;
Publication date: 2019-01-28
TBC1D8B Loss-of-Function Mutations Lead to X-Linked Nephrotic Syndrome via Defective Trafficking Pathways.
Author(s): Dorval G, Kuzmuk V, Gribouval O, Welsh GI, Bierzynska A, Schmitt A, Miserey-Lenkei S, Koziell A, Haq S, Benmerah A, Mollet G, Boyer O, Saleem MA, Antignac C
Source: Am J Hum Genet 2019 Jan 6;
Publication date: 2019-01-6
Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS.
Author(s): Yao T, Udwan K, John R, Rana A, Haghighi A, Xu L, Hack S, Reich HN, Hladunewich MA, Cattran DC, Paterson AD, Pei Y, Barua M
Source: Clin J Am Soc Nephrol 2019 Jan 15;
Publication date: 2019-01-15
Genetic studies of focal segmental glomerulosclerosis: a waste of scientific time?
Author(s): Howie AJ
Source: Pediatr Nephrol 2018 Dec 27;
Publication date: 2018-12-27
+ Show 20 more...